Find An Allergist / Immunologist | Pollen Levels | Journal of Allergy and Clinical Immunology | Annual Meeting   Contact    About AAAAI    Search
Patients & Consumers Conditions En Español Find an Allergist / Immunologist Just for Kids New Research Parent Resources Pollen Levels Publications Request a Speaker School Tools Seniors The Virtual Allergist™ Treatments Donate Now Search by Condition (A-Z) Search by Topic Allergy & Asthma Issues Educational Brochures Elements of Allergy and Asthma Order Public Education Materials Allergy Shots Drug Guide Sublingual Immunotherapy (SLIT)		New Research - January 2009 Failure of azithromycin or montelukast to exert steroid sparing effect in small group of moderate to severe asthmatics This is a report of a multicenter ongoing study of children with moderate to severe asthma. The investigators wished to see if daily administration of azithromycin or montelukast would be steroid sparing. They screened 292 children to enter the study, but only 55 were randomized. In this small group they found that neither montelukast nor azithromycin was steroid sparing in a double-masked, parallel, multicenter evaluation. The primary outcome was time from randomization to inadequate asthma control in patients using budesonide/salmeterol. Reference Strunk RC, et al. Azithromycin or montelukast as inhaled corticosteroid sparing agents in moderate to severe childhood asthma study. J Allergy Clin Immunol 2008; 122:1138-1144. <back>
		© 1996-2009 · All Rights Reserved · American Academy of Allergy Asthma & Immunology Disclaimers and Contact Information · Site Map